2m 2m 2m 2m 2m 2m 2m
ACTINIUM PHARMA (ATNM)
NYSE
$1.51-$0.09 (-5.63%)
Price as of Oct 23, 2026 12:27 PM EDT- $50.3MMarket Cap
- 11.89%1-Year Change
- BiotechnologyIndustry
ACTINIUM PHARMA (ATNM)
$1.51-$0.09 (-5.63%)
ATNM | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.60 | ||
Change | +$0.22 (+15.94%) | ||
Open | $1.33 | ||
High | $1.66 | ||
Low | $1.33 | ||
Previous Close | $1.38 | ||
Volume | 828,818 | ||
30-Day Average Volume | 213,315 | ||
1-Week Change | 50.94% | ||
1-Month Change | 36.75% | ||
1-Year Change | 11.89% | ||
3-Year Change | -71.98% | ||
5-Year Change | -80.61% | ||
Fundamentals | |||
Shares Outstanding | 31.4M | ||
Total Assets | $40.2M | ||
Market Cap | $50.3M | ||
Enterprise Value | $13.8M | ||
Period: QTR TTM FY | |||
Revenue | $35.0M | ||
Net Income | $27.9M | ||
Free Cash Flow | -$5.7M | ||
EBIT | $27.9M | ||
EBITDA | $28.3M | ||
Net Working Capital | $28.5M | ||
EPS | $0.89 | ||
Enterprise Value/EBITDA | 0 | ||
Enterprise Value/Revenue | 0 | ||
P/B | 2 | ||
P/E | 2 | ||
PEG | 0 | ||
Price/Free Cash Flow | -9 | ||
Price/Operating Cash Flow | -10 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 30 | ||
Last Split Date | 08/11/2020 | ||
Earnings & Revenue